Katharina Tschoep

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Rolf Dieter Issels · 2 shared papers, 2013–2023 · strength 0.15
   • Paper Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ducta… DOI 10.1016/j.ejca.2022.12.009↗
   • Paper Gemcitabine and cisplatin combined with regional hyperthermia as second-line treatment in patients with gemcitabine-ref… DOI 10.3109/02656736.2012.740764↗
2. Marcus Bahra · 1 shared paper, 2023 · strength 0.11
   • Paper Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ducta… DOI 10.1016/j.ejca.2022.12.009↗
3. Wolfgang Erwin Thasler · 1 shared paper, 2023 · strength 0.11
   • Paper Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ducta… DOI 10.1016/j.ejca.2022.12.009↗
4. Rainer Fietkau · 1 shared paper, 2023 · strength 0.11
   • Paper Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ducta… DOI 10.1016/j.ejca.2022.12.009↗
5. Pirus Ghadjar · 1 shared paper, 2023 · strength 0.11
   • Paper Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ducta… DOI 10.1016/j.ejca.2022.12.009↗
6. Lucjan Stanislaw Wyrwicz · 1 shared paper, 2023 · strength 0.11
   • Paper Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ducta… DOI 10.1016/j.ejca.2022.12.009↗
7. Wolfram Trudo Knoefel · 1 shared paper, 2023 · strength 0.11
   • Paper Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ducta… DOI 10.1016/j.ejca.2022.12.009↗
8. Volker Heinemann · 1 shared paper, 2023 · strength 0.11
   • Paper Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ducta… DOI 10.1016/j.ejca.2022.12.009↗
9. Uwe Pelzer · 1 shared paper, 2023 · strength 0.11
   • Paper Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ducta… DOI 10.1016/j.ejca.2022.12.009↗
10. Helmut Oettle · 1 shared paper, 2023 · strength 0.11
    • Paper Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ducta… DOI 10.1016/j.ejca.2022.12.009↗
11. Jens Werner · 1 shared paper, 2023 · strength 0.11
    • Paper Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ducta… DOI 10.1016/j.ejca.2022.12.009↗
12. Stefan Hubert Boeck · 1 shared paper, 2023 · strength 0.11
    • Paper Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ducta… DOI 10.1016/j.ejca.2022.12.009↗
13. Christiane J. Bruns · 1 shared paper, 2023 · strength 0.11
    • Paper Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ducta… DOI 10.1016/j.ejca.2022.12.009↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.